VDAC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.016780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.673600E-01
Normal-vs-Stage2
8.369600E-02
Normal-vs-Stage3
7.310600E-01
Normal-vs-Stage4
1.538810E-01
Stage1-vs-Stage2
6.829400E-01
Stage1-vs-Stage3
3.657000E-01
Stage1-vs-Stage4
6.826200E-01
Stage2-vs-Stage3
1.171980E-01
Stage2-vs-Stage4
8.127600E-01
Stage3-vs-Stage4
2.149800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.076620E-01
Normal-vs-AfricanAmerican
1.694580E-01
Normal-vs-Asian
1.676830E-01
Caucasian-vs-AfricanAmerican
4.429400E-01
Caucasian-vs-Asian
3.727200E-01
AfricanAmerican-vs-Asian
3.241000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.665900E-02
Normal-vs-Female
1.215200E-01
Male-vs-Female
5.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.592400E-01
Normal-vs-Age(41-60Yrs)
5.238100E-02
Normal-vs-Age(61-80Yrs)
1.449400E-01
Normal-vs-Age(81-100Yrs)
1.039570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.254800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.810200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.720800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.101200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.499200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.643220E-01
Normal-vs-Daily Drinker
1.669360E-01
Normal-vs-Weekly Drinker
2.567200E-01
Normal-vs-Occasional Drinker
7.298100E-02
Normal-vs-Social Drinker
1.013600E-01
Non Drinker-vs-Daily Drinker
7.540400E-01
Non Drinker-vs-Weekly Drinker
3.208000E-01
Non Drinker-vs-Occasional Drinker
7.904400E-01
Non Drinker-vs-Social Drinker
7.873600E-01
Daily Drinker-vs-Weekly Drinker
4.512200E-01
Daily Drinker-vs-Occasional Drinker
5.586000E-01
Daily Drinker-vs-Social Drinker
9.829800E-01
Weekly Drinker-vs-Occasional Drinker
1.830010E-01
Weekly Drinker-vs-Social Drinker
4.169600E-01
Occasional Drinker-vs-Social Drinker
5.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.410300E-02
Normal-vs-Grade 2
1.828000E-02
Normal-vs-Grade 3
1.262220E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.148310E-02
Grade 1-vs-Grade 3
8.317300E-03
Grade 1-vs-Grade 4
8.410300E-02
Grade 2-vs-Grade 3
7.008200E-01
Grade 2-vs-Grade 4
1.828000E-02
Grade 3-vs-Grade 4
1.262220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.845420E-01
Normal-vs-NonDiabetic
8.647800E-02
Diabetic-vs-NonDiabetic
3.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.866500E-02
Normal-vs-NoPancreatitis
1.198620E-01
Pancreatitis-vs-NoPancreatitis
3.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.781900E-02
Normal-vs-N1
9.653500E-02
N0-vs-N1
9.868000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.285520E-02
Normal-vs-TP53-NonMutant
2.904200E-01
TP53-Mutant-vs-TP53-NonMutant
4.813300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
